- Home
- FLWS vs XFOR Comparison
FLWS vs XFOR Comparison
Compare FLWS & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLWS | XFOR |
|---|---|---|
| Founded | 1976 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.0M | 323.5M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | FLWS | XFOR |
|---|---|---|
| Price | $4.07 | $3.55 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.50 | ★ $28.50 |
| AVG Volume (30 Days) | ★ 683.7K | 420.2K |
| Earning Date | 01-29-2026 | 03-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,585,455,000.00 | $33,979,000.00 |
| Revenue This Year | N/A | $1,266.01 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2925.74 |
| 52 Week Low | $2.93 | $1.35 |
| 52 Week High | $9.12 | $17.96 |
Technical Indicators
Market Signals| Indicator | FLWS | XFOR |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 41.78 |
| Support Level | $3.80 | $3.52 |
| Resistance Level | $4.25 | $3.74 |
| Average True Range (ATR) | 0.32 | 0.18 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 21.69 | 7.56 |
Price Performance
Historical ComparisonAbout FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.